Alembic Pharma shares hit 20% upper circuit after 81% YoY rise in Q2 PAT

How 1 sources are covering this

• Business StandardCenter·2h ago

  Alembic Pharma shares hit 20% upper circuit after 81% YoY rise in Q2 PAT

  Alembic Pharma's revenue from operations increased by 36 per cent YoY to ₹2,603 crore during the said period from ₹1,910 crore a year ago.

  Read at Business Standard →